U.S. markets closed

Guardion Health Sciences, Inc. (GHSI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.1493-0.0022 (-1.45%)
At close: 04:00PM EDT
0.1500 +0.00 (+0.47%)
After hours: 07:55PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected


Previous Close0.1515
Bid0.1470 x 900
Ask0.1520 x 1100
Day's Range0.1472 - 0.1600
52 Week Range0.1380 - 1.9800
Avg. Volume6,144,343
Market Cap9.171M
Beta (5Y Monthly)0.78
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for GHSI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Guardion Health Sciences, Inc.
    Analyst Report: Zimmer Biomet Holdings, Inc.Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Close to 60% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products; the remaining portion is primarily related to spine and dental products.
    Fair Value
    Economic Moat
    7 months agoMorningstar
View more
  • GlobeNewswire

    ISS Recommends Guardion Stockholders Vote for the Increase in Shares for Equity Plan and for the Reverse Stock Split at Guardion’s Upcoming 2022 Annual Stockholders’ Meeting

    HOUSTON, June 09, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) announced that independent proxy advisory firm ISS recommends that Guardion stockholders vote in favor of proposal 3 and proposal 4 at the Company’s upcoming Annual Meeting of Stockholders (the “Annual Meeting”) on June 16, 2022. Only stockholders of record on the record date of April 18, 2022 are eligible to attend and vote on proposals presented at the Annual Meeting. The Boar

  • GlobeNewswire

    Guardion Health Sciences Announces Agreement with OmegaQuant Laboratories

    HOUSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced an agreement with OmegaQuant Laboratories (“OmegaQuant”) to provide Guardion with analytic testing and laboratory support services for current and future products. Guardion is a clinical nutrition company that offers a portfolio of science-based, clinically-developed products that are designed to support the health needs of consumers, healthcare professionals and provi

  • GlobeNewswire

    Guardion Health Sciences Announces New Viactiv Omega Boost Gel Bites Now Available for Purchase on Amazon

    Consumers May Now Purchase Viactiv Omega Boost 1,200 mg Omega-3 Gel Bites Directly from Amazon Viactiv Omega Boost Gel Bites Provide 10x More Omega-3 Than the Leading Fish Oil Gummy, Without the Fishy Taste and Sugar Associated with Other Omega-3 Products HOUSTON, May 26, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced the availability of Viactiv Omega Boost Gel Bites on Guardion is a clinical nutrition company that offer